Inflexion Sells Lintbells to Vetnique Labs, Achieving 5.5x ROI

European mid-market private equity firm Inflexion is to sell its investment in Lintbells, a specialist in pet supplements which are sold under the YuMOVE brand name, to to Vetnique Labs, a portfolio company of Gryphon Investors.

The sale marks a highly successful exit for Inflexion Enterprise Fund IV, generating a 5.5x return.

Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
Sign up

Hertfordshire, UK-based Lintbells was founded almost two decades ago by Dr John Howie DL and John Davies, to provide pets and their owners with scientifically supported supplements to support chronic health conditions. Lintbells’ YuMOVE products a joint mobility supplements for dogs and cats, as well as supplements to support digestive health, anxiety, skin & coat and dental.

Since the 2017 investment, Inflexion’s in-house teams have supported Lintbells across a range of growth opportunities, including its expansion of the highly successful direct-to-consumer channel. Inflexion has also supported the successful expansion of Lintbells into the US both organically and through the acquisition of Walkin’ Pets.

In addition to Lintbells, Inflexion has significant experience in the pet-care market with previous successful investments including Medivet and Kynetec.

 

Source: Private Equity Wire

Can’t stop reading? Read more